LTRN – lantern pharma inc. (US:NASDAQ)
Stock Stats
News
Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials
Lantern Pharma (NASDAQ:LTRN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
Lantern Pharma Inc. (LTRN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Form 8-K Lantern Pharma Inc. For: Nov 13
Form 10-Q Lantern Pharma Inc. For: Sep 30
Form 8-K Lantern Pharma Inc. For: Sep 19
Form 4 Lantern Pharma Inc. For: Sep 19 Filed by: KEYSER D JEFFREY
Form 4 Lantern Pharma Inc. For: Sep 19 Filed by: Chandru Vijay
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.